Streetbeat News

Price Targets

SHPW

Needham has maintained a Buy rating on Shapeways Holdings but lowered its price target from $8 to $4.5. This has led to a decrease in the trading price of Shapeways Holdings shares.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 4:36 pm

NVDA

NVIDIA's stock is trading higher following UBS's decision to raise its estimates and increase its price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 4:34 pm

BBLG

Zacks Small-Cap Research has set a price valuation of $7.50 for Bone Biologics (BBLG).

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 4:04 pm

SBEV

EF Hutton analyst Ben Piggott maintains a 'Buy' rating on Splash Beverage Group (AMEX:SBEV), but lowers the price target from $3 to $2.5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 4:04 pm

LSTA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Lisata Therapeutics (NASDAQ:LSTA) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 4:03 pm

PED

EF Hutton analyst Ignacio Bernaldez maintains a 'Buy' rating on PEDEVCO (AMEX:PED), but has lowered the price target from $2.75 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 4:01 pm

ARCT

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Arcturus Therapeutics (NASDAQ:ARCT) and maintained a $51 price target.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:52 pm

IKT

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Inhibikase Therapeutics (NASDAQ:IKT) and maintained a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:51 pm

CYBN

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Cybin (AMEX:CYBN) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 3:50 pm

MNDY

Citigroup analyst Steven Enders maintains a Buy rating on Monday.Com (NASDAQ:MNDY) and raises the price target from $224 to $234.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 3:47 pm